How the carbon footprint of medications can be integrated into our prescriptions
Kidney International · 2026-06 · 109 (6) · 1052-1055
DOI: 10.1016/j.kint.2026.03.005 ↗Kurz gefasst
Editorial in der Zeitschrift Kidney International, 2026-06. Verfasst von Maryvonne Hourmant und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Clinical Immunology, University Hospital, Nantes, France. Electronic address: hourmant.maryvonne@bbox.fr. Hauptthemen laut MEDLINE: Carbon Footprint, Drug Prescriptions, Antihypertensive Agents. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Clinical Immunology, University Hospital, Nantes, France. Electronic address: hourmant.maryvonne@bbox.fr.
- Ecovamed, Chaville, France.
- Neuroendocrine and Germinal Differentiation and Communication (NorDiC) Institut National de la Santé et de la Recherche Médicale (INSERM) U1239-Galenic Pharmaceutical Team, Unité de Formation et de Recherche (UFR) of He…
Zitieren
APA
Hourmant, M., Taillemitte, S., & Bounoure, F. (2026). How the carbon footprint of medications can be integrated into our prescriptions. Kidney International, 109(6), 1052-1055. https://doi.org/10.1016/j.kint.2026.03.005
Vancouver
Hourmant M, Taillemitte S, Bounoure F. How the carbon footprint of medications can be integrated into our prescriptions. Kidney International. 2026;109(6):1052-1055. doi:10.1016/j.kint.2026.03.005
BibTeX
@article{Hourmant2026,
author = {Hourmant, Maryvonne and Taillemitte, Sébastien and Bounoure, Frédéric},
title = {How the carbon footprint of medications can be integrated into our prescriptions},
journal = {Kidney International},
year = {2026},
volume = {109},
number = {6},
pages = {1052--1055},
doi = {10.1016/j.kint.2026.03.005}
}
EUVIMED